Breast Cancer

Medicaid expansion was associated with a 2% drop in cancer mortality, a recent study found.

The new optical sensing method is based on multi-pass spectroscopy and can detect the presence of 1 molecule of formaldehyde in a million air particles, or 1 part per million, even in the presence of gasses that often interfere with optical measurements.

Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes.

Researchers hope clinical trials will begin soon to evaluate oral LMTK3 inhibitors across cancer types.

PD-L1 IHC 22C3 pharmDx will aid in the identification of patients with triple-negative breast cancer eligible for treatment with pembrolizumab.

The newest indication is the first approval of pembrolizumab for breast cancer, according to Merck.

Pharmacists and other medical experts also have a great opportunity to use social media to correct misconceptions, provide guidance, and steer patients toward credible sources.

A new breast cancer combination treatment may help patients with certain gene mutations, according to a study published in Molecular Cell.

Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.

Study to evaluate paclitaxel plus encequidar with dostarlimab +/- carboplatin in patients with breast cancer.

Approximately 30% of women gain weight following chemotherapy for breast cancer, gut bacteria may be why.

FDA approves FoundationOne Liquid CDx as a companion diagnostic for alpelisib in advanced or metastatic breast cancer, rucaparib in advanced ovarian cancer, and alectinib in a specific type of metastatic non–small cell lung cancer.

An axillary lymph node dissection, which is the surgical removal of 10 to 20 lymph nodes from the breast, is a procedure conducted in up to 25% of women with breast cancer to disable symptoms of arm swelling.

Lipid-lowering medication may be an effective adjuvant cancer therapy.

Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work.

The authors concluded that a single dose of targeted intraoperative radiotherapy should be an option accessible to health care providers and discussed with patients.

Study findings align with recent recommendations from the National Comprehensive Cancer Network for preventing febrile neutropenia in patients with early-stage breast cancer.

Patients should talk to their health care team about when to reschedule a postponed or cancelled screening appointment.

Lenvatinib (Lenvima) plus pembrolizumab (Keytruda) showed early antitumor activity and tolerability in previously treated triple-negative breast cancer patients with advanced solid tumors.

Trial shows that olaparib, a poly ADP ribose polymerase inhibitor that is the first cancer drug to target an inherited genetic fault, can be used successfully to treat prostate cancers with a weakness in the ability to repair damaged DNA.

Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer.

Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those who did not.

A new test may help direct treatments for patients with rare breast cancer mutations.

Understanding the role of abemaciclib (Verzenio) in managing patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer is crucial.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively.

In a phase 3 clinical trial, oral paclitaxel was found to be just as effective intravenous paclitaxel in metastatic breast cancer.

The current study found no link between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality.

Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.

Women who typically have a better prognosis in the primary breast cancer setting experienced worse survival after a second primary breast cancer.